Sequenom Announces Participation At The 25th Annual Roth Conference

     Sequenom Announces Participation At The 25th Annual Roth Conference

PR Newswire

SAN DIEGO, March 15, 2013

SAN DIEGO, March 15, 2013 /PRNewswire/ --Sequenom, Inc. (NASDAQ: SQNM), a
life sciences company providing innovative diagnostic testing and genetic
analysis solutions, today announced the Company's participation at the 25^th
Annual Roth Conference at the Ritz-Carlton Hotel in Laguna Niguel, CA on March
17-20, 2013.

William Welch, M.B.A, President and Chief Operating Officer, will present on
Monday, March 18, 2013, beginning at 12:30 p.m. PT, to provide an overview of
and update on the Company. The presentation is expected to last approximately
25 minutes and will be web cast live through the "Investors" section of the
Sequenom website at An audio replay will be available for
30 days following the initial presentation web cast. 

About Sequenom

Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to
improving healthcare through revolutionary genetic analysis solutions.
Sequenom develops innovative technology, products and diagnostic tests that
target and serve discovery and clinical research, and molecular diagnostics
markets. The company was founded in 1994 and is headquartered in San Diego,
California. Sequenom maintains a Web site at to which
Sequenom regularly posts copies of its press releases as well as additional
information about Sequenom. Interested persons can subscribe on the Sequenom
Web site to email alerts or RSS feeds that are sent automatically when
Sequenom issues press releases, files its reports with the Securities and
Exchange Commission or posts certain other information to the Web site.


SOURCE Sequenom, Inc.

Contact: Marcy Graham, Senior Director, Investor Relations & Corp Comm,
Sequenom, Inc., +1-858-202-9028,; or Jakob Jakobsen,
Media Contact, Chandler Chicco Agency, +1-310-309-1003,
Press spacebar to pause and continue. Press esc to stop.